Cholesterol synthesis inhibitors protect against platelet-activating factor-induced neuronal damage
<p>Abstract</p> <p>Background</p> <p>Platelet-activating factor (PAF) is implicated in the neuronal damage that accompanies ischemia, prion disease and Alzheimer's disease (AD). Since some epidemiological studies demonstrate that statins, drugs that reduce choleste...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-01-01
|
Series: | Journal of Neuroinflammation |
Online Access: | http://www.jneuroinflammation.com/content/4/1/5 |